THE PATHOLOGY OF MELANOMAAN INTERNATIONAL COURSE

Faculty list

👤 The Course Organizer – Professor Raymond L. Barnhill, MD

We are honored to introduce Professor Raymond L. Barnhill, organizer of the International Melanoma Course and a world-renowned expert in melanoma pathology and dermatopathology 🧬.

🏛️ Professor Barnhill is an International Consultant for Melanoma at Institut Curie and Professor at UniversitĂ© Paris CitĂ© (Paris, France). He also serves as a Visiting Faculty Scientist/Professor at Cedars-Sinai Medical Center (Los Angeles, USA).

🎓 With an outstanding academic background spanning Tulane University, Duke University School of Medicine, and the University of Oxford, and senior appointments at Yale, Harvard Medical School, Johns Hopkins University, UCLA, and other leading institutions, Professor Barnhill has held major clinical and academic leadership roles worldwide.

🔬 His research has profoundly shaped the understanding of melanoma biology, angiogenesis, and cancer metastasis, including the discovery—together with Dr. Claire Lugassy—of angiotropic extravascular migratory metastasis, now recognized as an additional pathway of cancer spread.
📚 Professor Barnhill has authored numerous landmark publications and reference textbooks, including the Textbook of Dermatopathology, and has contributed to multiple editions of the WHO Classification of Skin Tumours. He is also the founder of the North American and International Melanoma Pathology Study Groups.

🌍 For nearly 30 years, he has organized international courses, symposia, and workshops on melanocytic lesions, including five International Melanoma Courses at Institut Curie, and continues to lecture internationally.

We are proud to have Professor Barnhill leading this course and sharing his exceptional expertise with the global melanoma community.

Institut Curie and University Paris Cité, Paris, France

Bastian Boris

University of California,
San Francisco, USA

Busam Klaus

👨‍⚕️ Prof. Busam is

Professor of Pathology and Laboratory Medicine at Weill Cornell Medical College and Director of Dermatopathology at Memorial Sloan Kettering Cancer Center (MSKCC), where he also serves as Medical Director of the Immunohistochemistry Laboratory.

🎓 A graduate of the University of Freiburg (Germany), he completed his residency in Anatomic Pathology at Brigham and Women’s Hospital followed by a fellowship in Dermatopathology within the Harvard program.

🔬 His research has significantly advanced the diagnostic accuracy and prognostic evaluation of melanocytic tumors and other skin cancers. He leads the pathology core of the NIH-funded InterMel international melanoma research consortium and received the Founders Award of the American Society of Dermatopathology (ASDP) in 2021 đźŹ†.

📚 Prof. Busam has co-edited and contributed to major reference textbooks, including the WHO Classification of Skin Tumours, and plays a key role in international cancer reporting as a member and chair of ICCR expert committees for melanoma and Merkel cell carcinoma.

Memorial Sloan Kettering Cancer Center,
New York, USA

Cree Ian

UCL Institute of Ophthalmology,
University College
London, United Kingdom

Duncan Lyn

👤 Professor Lyn Duncan

🏛️ is a Professor of Pathology at Harvard Medical School and a Dermatopathologist at Massachusetts General Hospital, where she has been a leading member of the dermatopathology faculty for more than three decades. She is internationally recognized for her expertise in melanocytic neoplasia, prognostic factors in early-stage melanoma, 🧬 sentinel lymph node pathology, and the classification of cutaneous lymphomas.

📚 She is the author of over 100 scientific publications, more than 60 textbook chapters, and two reference textbooks in dermatopathology. Professor Duncan also served as an editor and co-author of the 5th edition of the WHO Classification of Skin Tumours, and previously as President of the American Society of Dermatopathology.

👩‍🏫 A dedicated educator and mentor, Professor Duncan is an active member of the International Melanoma Pathology Working Group. We are proud to have her share her expertise with the international melanoma community at International Melanoma Course 2026.

Massachusetts General Hospital and Harvard Medical School, Boston, USA

Elder David

University of Pennsylvania,
Philadelphia, USA

De la Dourchardière Arnaud

Centre Léon Bérard,
Lyon, France

Castle Biosciences, Friendswood, TX, USA

Lugassy Claire

Institut Curie, Paris, France

Institut Curie and University Paris Cité, Paris, France

Scolyer Richard

Melanoma Institute of Australia and the University of Sydney, Australia